The RESET System Pivotal Clinical Trial (Protocol Revision K)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 264 participants.

Also called NCT04101669

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 264 participants (planned count) (from the registry)
Sponsor
Morphic Medical Inc. (from the registry)
Registry
  • NCT NCT04101669
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04101669. Randomized; triple masking; primary purpose treatment. Start 2019-09-09 (actual); primary completion 2027-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Acronym
STEP-1
Condition
Diabetes type2
Condition
Obesity
Intervention (Device)
RESET Liner
Intervention (Other)
Sham
Lead sponsor
Morphic Medical Inc. (class: industry)
Collaborator
Biostatistical Consulting, Inc. (class: other)

Record details

Record id
cardio:ct-nct04101669
Content hash
4b5c3be76fa645f73c30733bdd75f691a0c01d69369466d67ec56c6a020eb8d4